Dr. Reddy's Laboratories Ltd. NSE: DRREDDY | BSE: 500124

Mid-range Performer

Download real time

1301.00 -20.50 (-1.55%)

27.55% Gain from 52W Low

1.8M

NSE+BSE Volume

NSE 27 Jun, 2025 3:31 PM (IST)

Target Downgrade

Citi maintains a 'Sell' rating on Dr. Reddy's Laboratories; cuts the target price to Rs 990 See details

Dr. Reddy's Laboratories Ltd. share price target

Dr. Reddy's Laboratories Ltd. has an average share price target of 1343.25. The consensus estimate represents an upside of 3.25% from the last price of 1301. View 21 reports from 9 analysts offering long-term price targets for Dr. Reddy's Laboratories Ltd..

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Load latest Google or static link led you to an intermediate page.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report		Discuss
	29 Jun 2025	Dr. Reddy's Labs	Consensus Share Price Target	1301.00	1268.74	-	-2.48	hold	pdf Detailed Estimates
	29 Oct 2022	Dr. Reddy's Labs	BOB Capital Markets Ltd.	1301.00		4433.70 (-70.66%)	Pre-Bonus/ Split	Hold	pdf post cache		Broker Report Dr Reddy's Labs (HOLD): US launch of gRevlimid buoys quarter BOB Capital Markets Ltd. Q2 revenue up 9% YoY on sales of gRevlimid in the US; gross margin expansion aids EBITDA growth of 42% YoY pdf Copy Link Share on Share on Share on Share on Alert
	29 Oct 2022	Dr. Reddy's Labs	Motilal Oswal Target	1301.00	5180.00	4433.70 (-70.66%)	Target met	Buy	pdf post cache		Broker Report Russia recovers, while PSAI still a drag on earnings Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	01 Aug 2022	Dr. Reddy's Labs	SMC online	1301.00		4096.30 (-68.24%)	Pre-Bonus/ Split	Results Update	pdf post cache		Broker Report Dr. Reddy`s Laboratories SMC online pdf Copy Link Share on Share on Share on Share on Alert
	29 Jul 2022	Dr. Reddy's Labs	Prabhudas Lilladhar Target	1301.00	4750.00	4110.45 (-68.35%)	Target met	Buy	pdf post cache		Broker Report DR REDDY'S LABS Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	29 Jul 2022	Dr. Reddy's Labs	ICICI Direct Target	1301.00	4750.00	4090.35 (-68.19%)	Target met	Buy	pdf post cache		Broker Report Dr Reddy's Laboratories ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	29 Jun 2022	Dr. Reddy's Labs	Axis Direct Target	1301.00	4750.00	4364.35 (-70.19%)	Target met	Buy	pdf post cache		Broker Report Company Update:Dr Reddys Labs Axis Direct We recommend a BUY rating on the stock with a TP of Rs 4,750. pdf Copy Link Share on Share on Share on Share on Alert
	24 Jun 2022	Dr. Reddy's Labs	ICICI Securities Limited Target	1301.00	4925.00	4294.90 (-69.71%)	Target met	Buy	pdf post cache		Broker Report Investor meet highlights ICICI Securities Limited DRL has devised a two-pronged strategy to drive long-term growth, classified as Horizon 1 and Horizon 2. Horizon 1 – Growing the core, short-medium term drivers of growth. ? Horizon 2 Building the future, short-long term drivers of growth pdf Copy Link Share on Share on Share on Share on Alert
	23 Jun 2022	Dr. Reddy's Labs	Geojit BNP Paribas Target	1301.00	5026.00	4309.65 (-69.81%)	Pre-Bonus/ Split	Buy	pdf post cache		Broker Report DR. REDDY'S LABORATARIES Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	22 Jun 2022	Dr. Reddy's Labs	ICICI Direct Target	1301.00	4960.00	4260.90 (-69.47%)	Target met	Buy	pdf post cache		Broker Report Dr Reddy's Laboratories ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	22 Jun 2022	Dr. Reddy's Labs	Prabhudas Lilladhar Reco Target	1301.00	4900.00	4294.90 (-69.71%)	Target met	Buy	pdf post cache		Broker Report DR REDDY'S LABS Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
more loading

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

Advisor Screeners